Stability of Tigecycline in Different Types of Peritoneal Dialysis Solutions
- 1 July 2016
- journal article
- Published by SAGE Publications in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
- Vol. 36 (4) , 410-414
Abstract
Introduction: Intraperitoneal tigecycline is a potential option for the treatment of peritoneal dialysis (PD)-associated peritonitis caused by microorganisms resistant to commonly used antibiotics. However, the stability of tigecycline must be assessed in the PD solution before evaluating its safety and therapeutic efficacy in PD-associated peritonitis. The objective of this study was to investigate the stability of tigecycline in 3 types of PD solutions at different temperatures for various time points. Methods: A total of 27 PD bags (9 PD bags for each type of PD solution; 1.5% glucose, 7.5% icodextrin, and 1.5% glucose pH neutral) containing 2 μg/mL of tigecycline were prepared and stored at either 4, 25, or 37°C. An aliquot was withdrawn immediately before (0 hour) and after pre-defined time points. Each sample was analyzed in duplicate for the concentration of tigecycline using a stability-indicating high-performance liquid chromatography (HPLC) technique. Samples were also assessed for pH, color changes, and evidence of precipitation immediately after preparation and on each day of analysis. Results: Tigecycline in all 3 types of PD solutions retained more than 90% of its initial concentration for at least 216, 72, and 8 hours at 4, 25, and 37°C, respectively. There was no evidence of precipitation at any time under the tested storage conditions. The pH and color of tigecycline admixed PD solutions stored at 4, 25, and 37°C remained essentially unchanged for 336, 96, and 48 hours respectively. Conclusion: The results obtained from the study provide a platform for future clinical studies aiming to determine the safety and therapeutic efficacy of intraperitoneally administered tigecycline for the treatment of PD-associated peritonitis.Keywords
This publication has 20 references indexed in Scilit:
- Peritoneal Dialysis–Associated Peritonitis Rates and Outcomes in a National Cohort are not Improving in the Post-Millennium (2000 – 2007)Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2011
- Relapsing and Recurrent Peritoneal Dialysis–Associated Peritonitis: A Multicenter Registry StudyAmerican Journal of Kidney Diseases, 2011
- Systematic Review and Meta-Analysis of the Effectiveness and Safety of Tigecycline for Treatment of Infectious DiseaseAntimicrobial Agents and Chemotherapy, 2011
- Vancomycin-resistant enterococci peritonitis development after shifting from hemodialysis to peritoneal dialysisRenal Failure, 2010
- Peritoneal Dialysis-Related Infections Recommendations: 2010 UpdatePeritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2010
- Susceptibility to tigecycline of isolates from samples collected in hospitalized patients with secondary peritonitis undergoing surgeryDiagnostic Microbiology and Infectious Disease, 2010
- Use of a Novel Antibiotic (Tigecycline) in the Treatment of Peritoneal Dialysis‐Associated MRSA PeritonitisDialysis & Transplantation, 2008
- EUCAST Technical Note on tigecyclineClinical Microbiology and Infection, 2006
- Enterobacteriaceae peritonitis complicating peritoneal dialysis: A review of 210 consecutive casesKidney International, 2006
- Drug Therapy in Patients Undergoing Continuous Ambulatory Peritoneal DialysisClinical Pharmacokinetics, 1990